Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05736185
Other study ID # EIT-PEEPstudy
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 25, 2023
Est. completion date May 30, 2024

Study information

Verified date November 2023
Source Southeast University, China
Contact liu ling, phD
Phone +8613851435472
Email liulingdoctor@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lung injury. Positive end-expiratory pressure (PEEP), as one of main component of MV, has been widely used in the clinical practice. However, how to best set PEEP is still a difficult problem for moderate to severe ARDS patients. EIT, an imaging tool evaluating the regional ventilation distribution at the bedside, can achieve the individual PEEP selection for all mechanically ventilated patients. This article compared the effect of PEEP titrated guided by EIT with fraction of inspired oxygen (FiO2)-PEEP table on the ventilation-perfusion mismatch.


Recruitment information / eligibility

Status Recruiting
Enrollment 69
Est. completion date May 30, 2024
Est. primary completion date May 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Intubated patients with moderate and severe ARDS (Berlin definition, PaO2/FiO2 =200 mmHg at PEEP 5 cmH2O) 2. undergoing deep sedation on controlled mechanical ventilation within72 hours after ARDS onset Exclusion Criteria: 1. age <18 years old 2. patient undergoing legal protection 3. contra-indications to EIT (e. g. severe chest trauma or wounds) 4. pneumothorax 5. patient undergoing ECMO 6. pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PEEP selection
Electric impedance tomography-guided PEEP titration

Locations

Country Name City State
China Zhongda Hospital, School of Medicine, Southeast University Nanjing Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Southeast University, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in ventilation-perfusion mismatch between EIT-PEEP, low-PEEP, and high PEEP EIT-PEEP was obtained by EIT, low-PEEP was obtained by low FIO2-PEEP table, and high-PEEP was obtained by high FIO2-PEEP table. up to 24 hours
Secondary difference in center of ventilation (COV) between EIT-PEEP, low-PEEP, and high PEEP COV was obtained by EIT monitoring up to 24 hours
Secondary Difference in dead space measured with EIT between EIT-PEEP, low-PEEP, and high PEEP dead space was obtained by EIT monitoring up to 24 hours
Secondary Difference in shunt measured with EIT between EIT-PEEP, low-PEEP, and high PEEP shunt was obtained by EIT monitoring up to 24 hours
Secondary Difference in wasted ventilation measured with EIT between EIT-PEEP, low-PEEP, and high PEEP wasted ventilation was obtained by EIT monitoring up to 24 hours
Secondary Difference in wasted perfusion measured with EIT between EIT-PEEP, low-PEEP, and high PEEP wasted perfusion was obtained by EIT monitoring up to 24 hours
Secondary ventilation distribution measured with EIT between EIT-PEEP, low-PEEP, and high PEEP ventilation distribution was obtained by EIT in difference regions up to 24 hours
Secondary perfusion distribution measured with EIT between EIT-PEEP, low-PEEP, and high PEEP perfusion distribution was obtained by EIT in difference regions up to 24 hours
Secondary Correlations between ventilation-perfusion mismatch and overdistension and lung collapses Overdistension (%) and lung collapses (%) will be assessed by EIT. These two values cannot be measured separately. V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. up to 24 hours
Secondary recruitment-to-inflation (R/I) ratio recruitment-to-inflation (R/I) ratio was computed between the two PEEP levels up to 24 hours
Secondary PaO2/FIO2 PaO2/FIO2 was obtained by gas analysis up to 24 hours
Secondary respiratory system mechanics respiratory system compliance included lung compliance, chest wall compliance, and respiratory system compliance. respiratory system resistance will be computed as the inverse of compliance. up to 24 hours
Secondary Correlation between V/Q mismatch markers and recruitability Recruitability will be assessed between 15 and 5 cmH2O by respiratory mechanics, as the recruited volumes value (in mL). R/I ratio will be derived from these data (no unit). V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. up to 24 hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05306392 - Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation N/A
Completed NCT04719182 - Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19
Completed NCT04274296 - Advisory Lead ARDS Respirator Management
Terminated NCT04954014 - Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients Phase 2
Recruiting NCT03215316 - Screening Expiratory Flow Limitation by Flow-time Curve N/A
Recruiting NCT04115514 - Treatment of ARDS With Instilled T3 Phase 2
Not yet recruiting NCT05061212 - The Mechanism of Extracellular Vesicles Containing Mitochondrial DNA in ARDS Lung Injury Caused by Extrapulmonary Sepsis
Not yet recruiting NCT04556864 - Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19
Completed NCT05693051 - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Recruiting NCT04174014 - Optimal PEEP Titration Combining Transpulmonary Pressure Measurement and Electric Impedance Tomography N/A
Enrolling by invitation NCT06164639 - Potential Biomarkers for Reflux Aspiration-induced Lung Injury.
Terminated NCT05384379 - Efficacy and Safety Evaluation of BZ371B in ARDS Patients Early Phase 1
Completed NCT04375735 - London's Exogenous Surfactant Study for COVID19 Phase 1/Phase 2
Completed NCT06224010 - Respiratory Drive and Inspiratory Effort in COVID-19 Associated ARDS
Not yet recruiting NCT04530188 - Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDS Phase 3
Completed NCT03405038 - Prone Position Impact in ARDS Patients on the Incidence of Central Venous Catheter Colonization
Recruiting NCT05148026 - Regional Citrate Anticoagulation for RRT During V-V ECMO N/A
Recruiting NCT04390360 - Smartphone Application for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction N/A
Completed NCT06197256 - Cardiac Dysfunction in Critically Ill Covid-19 Patients
Completed NCT04008225 - Study of the Effects of Bronchoalveolar Lavage Liquid in the ARDS on the Functioning of the Neutrophil Polynuclear System